Siemens Healthineers Adds Muscle To Global Antibody Testing Effort, In Talks With Vaccine Developers

The company now has US emergency use designation for its new SARS-CoV-2 test, which can run on its global installed base of 20,000 analyzers at a current capacity of 50 million tests per month.